These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36219238)
1. Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series. Zamò A; Gerhard-Hartmann E; Ott G; Anagnostopoulos I; Scott DW; Rosenwald A; Rauert-Wunderlich H Virchows Arch; 2022 Dec; 481(6):935-943. PubMed ID: 36219238 [TBL] [Abstract][Full Text] [Related]
2. Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm. Yoon N; Ahn S; Yong Yoo H; Jin Kim S; Seog Kim W; Hyeh Ko Y Oncotarget; 2017 Mar; 8(13):22014-22022. PubMed ID: 28423544 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified. Cho I; Yoon N; Hyeon J; Sim J; Yoo HY; Kim SJ; Kim WS; Ko YH Appl Immunohistochem Mol Morphol; 2020; 28(10):731-740. PubMed ID: 32287077 [TBL] [Abstract][Full Text] [Related]
4. Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia. Phang KC; Akhter A; Tizen NMS; Rahman FA; Zahratul Azma R; Elyamany G; Shabani-Rad MT; Masir N; Mansoor A J Clin Pathol; 2018 Mar; 71(3):215-220. PubMed ID: 28775174 [TBL] [Abstract][Full Text] [Related]
5. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas. Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; van Wezel T; van Eijk R; Ruano D; Tensen CP; Hauben E; Woei-A-Jin FJSH; Busschots AM; van den Berg A; Diepstra A; Vermeer MH; Vermaat JSP Virchows Arch; 2022 Mar; 480(3):667-675. PubMed ID: 35028710 [TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G; J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305 [TBL] [Abstract][Full Text] [Related]
7. Clinical impact of the cell-of-origin classification based on immunohistochemistry criteria and Lymph2Cx of diffuse large B-Cell lymphoma patients in a South-east Asian population: a single center experience and review of the literature. Lee J; Hue SS; Ko SQ; Tan SY; Liu X; Girard LP; Chan EHL; De Mel S; Jeyasekharan A; Chee YL; Koh LP; Poon LM Expert Rev Hematol; 2019 Dec; 12(12):1095-1105. PubMed ID: 31592693 [No Abstract] [Full Text] [Related]
8. The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms. Hwang HS; Yoon DH; Hong JY; Park CS; Lee YS; Ko YH; Kim SJ; Kim WS; Suh C; Huh J Ann Hematol; 2018 Dec; 97(12):2363-2372. PubMed ID: 30069703 [TBL] [Abstract][Full Text] [Related]
9. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma]. Han YS; Xue YQ; Yang HY; Zhang J; Pan JL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722 [TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907 [No Abstract] [Full Text] [Related]
11. Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma. Berker N; Yeğen G; Özlük Y; Doğan Ö Turk J Haematol; 2023 Aug; 40(3):162-173. PubMed ID: 37519110 [TBL] [Abstract][Full Text] [Related]
12. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824 [TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan. Chang ST; Chen SW; Ho CH; Kuo CC; Sakata S; Takeuchi K; Chuang SS J Formos Med Assoc; 2016 Nov; 115(11):961-967. PubMed ID: 27773559 [TBL] [Abstract][Full Text] [Related]
14. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Choi WW; Weisenburger DD; Greiner TC; Piris MA; Banham AH; Delabie J; Braziel RM; Geng H; Iqbal J; Lenz G; Vose JM; Hans CP; Fu K; Smith LM; Li M; Liu Z; Gascoyne RD; Rosenwald A; Ott G; Rimsza LM; Campo E; Jaffe ES; Jaye DL; Staudt LM; Chan WC Clin Cancer Res; 2009 Sep; 15(17):5494-502. PubMed ID: 19706817 [TBL] [Abstract][Full Text] [Related]
15. Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues. Rimsza LM; Wright G; Schwartz M; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Cook JR; Tubbs RR; Braziel RM; Delabie J; Miller TP; Staudt LM Clin Cancer Res; 2011 Jun; 17(11):3727-32. PubMed ID: 21364035 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China]. Chen Y; Chen H; Fu K; Zhu XZ; Irons R Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154 [TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes. Rao S; Epari S; Shet TM; Gujral S; Jain H; Bagal B; Senagar M; Shetty P; Moiyadi A; Goda JS; Gupta T Indian J Pathol Microbiol; 2023; 66(3):549-555. PubMed ID: 37530337 [TBL] [Abstract][Full Text] [Related]
18. Application of Hans Algorithm for Subcategorization of Diffuse Large B-Cell Lymphoma in Fine-Needle Aspiration Biopsy Cytology. Rohilla M; Garg S; Bal A; Das A; Gupta N; Dey P; Srinivasan R Acta Cytol; 2022; 66(1):14-22. PubMed ID: 34788750 [TBL] [Abstract][Full Text] [Related]
19. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171 [TBL] [Abstract][Full Text] [Related]
20. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases]. Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]